Inventor · disambiguated record
Michael Waterfield
Also filed as: MINGHETTI LUISA · WATERFIELD MICHAEL · WATERFIELD MICHAEL D · WATERFIELD MICHAEL DEREK
31 granted patents·5 pending applications·1,058 citations·filing 1985–2017
97Inventor score
Files withLUDWIG INST CANCER RES23CAMBRIDGE NEUROSCIENCE INC4ACORDA THERAPEUTICS INC3CAMBRIDGE NEUROSCIENCE RES1ICRF PATENTS LIMITED1
Top patents by PatentIndex Score
36 records- 0196US5530109ADNA encoding glial mitogenic factorsLUDWIG INST CANCER RES·Filed 1993·Granted Jun 25, 1996·136 cites·12 claims
- 0295US5824492APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1993·Granted Oct 20, 1998·127 cites·7 claims
- 0394US6849420B2Method for determining modulation of p110δ activityLUDWIG INST CANCER RES·Filed 2002·Granted Feb 1, 2005·95 cites·14 claims
- 0494US5716930AGlial growth factorsLUDWIG INST CANCER RES·Filed 1994·Granted Feb 10, 1998·109 cites·4 claims
- 0592US6482623B1Lipid kinaseLUDWIG INST CANCER RES·Filed 1997·Granted Nov 19, 2002·140 cites·20 claims
- 0692US4933294AMethod of detecting truncated epidermal growth factor receptorsICRF PATENTS LIMITED·Filed 1985·Granted Jun 12, 1990·186 cites·8 claims
- 0785US6274327B1Polypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1998·Granted Aug 14, 2001·40 cites·10 claims
- 0883US5594114ASchwann cell mitogenic factor, its preparation and useLUDWIG INST CANCER RES·Filed 1994·Granted Jan 14, 1997·61 cites·1 claims
- 0978US6232286B1Methods of stimulating mitogenesis in glial cells using glial mitogenic factorsCAMBRIDGE NEUROSCIENCE RES·Filed 1995·Granted May 15, 2001·27 cites·8 claims
- 1076US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 1173US5846824APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1997·Granted Dec 8, 1998·43 cites·8 claims
- 1272US7319019B1Glial mitogenic factors lacking an N-terminal signal sequenceACORDA THERAPEUTICS INC·Filed 1996·Granted Jan 15, 2008·18 cites·9 claims
- 1367US7541338B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 2, 2009·0 cites·14 claims
- 1465US5602096AMethod of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesisLUDWIG INST CANCER RES·Filed 1995·Granted Feb 11, 1997·11 cites·2 claims
- 1563US7422886B2Method for determining modulation of P110Δ activityLUDWIG INST CANCER RES·Filed 2005·Granted Sep 9, 2008·0 cites·6 claims
- 1663US6147190AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1995·Granted Nov 14, 2000·11 cites·22 claims
- 1761US5854220AGlial mitogenic factors, their preparation and useCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Dec 29, 1998·9 cites·3 claims
- 1857US7135456B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1995·Granted Nov 14, 2006·8 cites·18 claims
- 1955US2005064572A1Lipid kinaseFiled 2004·Application pending·0 cites
- 2054US2005106666A1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 2004·Application pending·0 cites
- 2151US6770467B2Screening method for ligands with class II P13 kinase modulating activityLUDWIG INST CANCER RES·Filed 2002·Granted Aug 3, 2004·0 cites·26 claims
- 2249US7422849B1Method for determining expression of a PI3 kinase geneLUDWIG INST CANCER RES·Filed 1999·Granted Sep 9, 2008·5 cites·10 claims
- 2348US8669347B2Truncated variant of the mammalian target for rapamycin (MTOR) proteinNEMAZANYY IVAN·Filed 2008·Granted Mar 11, 2014·0 cites·1 claims
- 2448US7285531B1Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factorLUDWIG INST CANCER RES·Filed 1995·Granted Oct 23, 2007·7 cites·6 claims
- 2547US5741689AMethods to inhibit serine kinase activity and to alter intersubunit binding activity of phosphatidylinositol 3-kinase, and serine kinase active sequence of the sameLUDWIG INST CANCER RES·Filed 1994·Granted Apr 21, 1998·10 cites·28 claims
- 2646US2014120099A1TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINUCL BUSINESS PLC·Filed 2013·Application pending·0 cites
- 2742US2017145391A1TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINLUDWIG INST CANCER RES·Filed 2017·Application pending·0 cites
- 2841US6972280B2Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Dec 6, 2005·5 cites·7 claims
- 2940US7192915B1Methods for treating multiple sclerosis with GGF-related polypeptidesLUDWIG INST CANCER RES·Filed 1996·Granted Mar 20, 2007·1 cites·3 claims
- 3040US2003064419A1Proteins, genes and their use for diagnosis and treatment of breast cancerFiled 2001·Application pending·0 cites
- 3139US6194377B1Methods for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Feb 27, 2001·1 cites·22 claims
- 3239US5621081AGlial mitogenic factorsLUDWIG INST CANCER RES·Filed 1995·Granted Apr 15, 1997·1 cites·4 claims
- 3338US7094749B1Glial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1996·Granted Aug 22, 2006·4 cites·5 claims
- 3438US5606032AProcess for preparing glial mitogenic factorsLUDWIG INST CANCER RES·Filed 1995·Granted Feb 25, 1997·1 cites·12 claims
- 3535US6204241B1Method for treating nervous system pathophysiologies using glial growth factorsCAMBRIDGE NEUROSCIENCE INC·Filed 1996·Granted Mar 20, 2001·1 cites·21 claims
- 3634US5792849AGlial mitogenic factors, their preparation and useLUDWIG INST CANCER RES·Filed 1995·Granted Aug 11, 1998·0 cites·62 claims
Join the waitlist — get patent alerts
Get an alert when Michael Waterfield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →